Provision Expands Into a New Market With the World’s Largest Regional Theme Park Company
Mar 01, 2016 12:30 pm UTC| Business
CHATSWORTH, Calif., March 01, 2016 -- Provision Interactive Technologies, Inc. ("Provision"), a subsidiary of Provision Holding, Inc. (OTCQB:PVHO), announced today that it has provided technology to the world’s largest...
Dermira to Present at Cowen and Company 36th Annual Health Care Conference
Mar 01, 2016 12:30 pm UTC| Business
MENLO PARK, Calif., March 01, 2016 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated therapies to improve the lives of...
Mar 01, 2016 12:30 pm UTC| Business
PARSIPPANY, N.J., March 01, 2016 -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced results of new data showing that EXPAREL® (bupivacaine liposome injectable suspension) infiltration compared to a standard...
Marinus Pharmaceuticals to Present at the Cowen & Company Annual Healthcare Conference
Mar 01, 2016 12:30 pm UTC| Business
RADNOR, Pa., March 01, 2016 -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today...
Raptor Pharmaceutical to Participate in the Cowen and Company 36th Annual Health Care Conference
Mar 01, 2016 12:30 pm UTC| Business
NOVATO, Calif., March 01, 2016 -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will participate in the following investor conference: Julie Anne Smith, President and Chief Executive Officer, will...
Akari Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference
Mar 01, 2016 12:15 pm UTC| Business
NEW YORK and LONDON, March 01, 2016 -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, development-stage biopharmaceutical company, announced today that Gur Roshwalb, M.D., Chief Executive Officer, will present...
Mar 01, 2016 12:10 pm UTC| Business
New York, March 01, 2016 -- Intrommune Therapeutics, a specialty biopharmaceutical company developing a patient-friendly platform for the treatment of food allergies, announced today that the U.S Patent and Trademark...